Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Buti

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Journal of Hepatology|December 31, 2017
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis CJavier Ampuero, Carlota Jimeno, Rosa Quiles, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvirJuan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Digestive Diseases and Sciences|February 3, 2023
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis BBeatriz Mateos-Muñoz, María Buti, Inmaculada Fernández Vázquez, et al.
Gastroenterologia Y Hepatologia|June 22, 2024
Characterizing Hepatitis Delta in Spain and the gaps in its managementSergio Rodríguez-Tajes, Adriana Palom, Álvaro Giráldez-Gallego, et al.
Antiviral Research|December 21, 2019
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failureQian Chen, Celia Perales, María Eugenia Soria, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Journal of Hepatology|December 31, 2017
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis CJavier Ampuero, Carlota Jimeno, Rosa Quiles, et al.
Alimentary Pharmacology & Therapeutics|May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvirJuan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Digestive Diseases and Sciences|February 3, 2023
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis BBeatriz Mateos-Muñoz, María Buti, Inmaculada Fernández Vázquez, et al.
Gastroenterologia Y Hepatologia|June 22, 2024
Characterizing Hepatitis Delta in Spain and the gaps in its managementSergio Rodríguez-Tajes, Adriana Palom, Álvaro Giráldez-Gallego, et al.
Antiviral Research|December 21, 2019
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failureQian Chen, Celia Perales, María Eugenia Soria, et al.
Pageof 10